The Federal Biomedical Agency has already developed three prototype vaccines against the new coronavirus.

According to the ria.ru web-site: "Today, three prototype vaccines have been created at the FMBA of Russia, which are recombinant proteins based on the SARS-CoV-2 surface S-protein epitopes, and immunogenicity studies in mice have been launched.”

The results of pilot studies are expected in June, the second phase is planned to be completed by the beginning of the third quarter.

© All rights are reserved. Citing to www.physiology.az is necessary upon using news.